Global Shrimp Disease Diagnostics Market Size, Regional Demand, Trends and Forecast to 2024-2032

Shrimp Disease Diagnostics Market Size And Forecast

Shrimp Disease Diagnostics Market size was valued at USD 157.15 Million in 2020 and is projected to reach USD 376.35 Million by 2028, growing at a CAGR of 11.56% from 2021 to 2028.

Growing demand for shrimp farming is the crucial aspect of the rise in the market revenue of Shrimp Disease Diagnostics as well as Developments in molecular diagnostics tools for disease detection foreseen to drive the market. The Global Shrimp Disease Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Shrimp Disease Diagnostics Market Definition

Shrimp has long remained a highly- celebrated product in the arena of international trade. According to recent studies, the global farmed shrimp production approximately reached 4 million tons in 2018, which represents a rise of 3-5% over the production registered in 2017. Although the overall increase in demand for seafood has been effective in the build-up of the shrimp farming landscape, the continued cases of viral diseases to farmed seafood remain a longstanding matter. The growing prevalence of viral infections in shrimp farming has called for effective diagnosis and appropriate medication, propelling the high need for shrimp disease diagnostics.

One of the highly exercised methods for disease diagnosis and prevention in shrimp farming has been a polymerase chain reaction, generally known as the PCR method. In parallel, with the growing need for quantitative study as well as high throughput screening formats in aquaculture, real-time PCR-based systems are grabbing end-user recognition in the Shrimp Disease Diagnostics Market. Companies, therefore, are focusing on the improvement of PCR-based systems with advanced designs, which in turn would facilitate accurate, sensitive, and flexible real-time analysis.

Global Shrimp Disease Diagnostics Market Overview

It is expected that owing to numerous advantages, the concept of biosecurity application to shrimp aquaculture will observe a notable growth to lessen losses in shrimp production owing to the high prevalence of diseases. Therefore, the use of sound epidemiological principles and a logical & structured approach is presumed to help achieve biosecurity, which is foreseen to be a major factor driving the Shrimp Disease Diagnostics Market. Growing demand for shrimp farming is anticipated to drive the adoption of shrimp disease diagnostics across the world. Though there has been a tremendous adverse influence of diseases on the global shrimp farming industry, the Shrimp Disease Diagnostics Market has continued to expand and has matured into a more sustainable market to suffice the high demand for disease diagnosis for the growing shrimp trade.

Developments in molecular diagnostics tools for disease detection are foreseen to drive the market. The screening of viral shrimp pathogens through the PCR laboratories requested by farmers has topped the list of biosecurity in shrimp farms, which prevents the spread of extremely infectious diseases such as WSD through the early molecular detection and adoption of the Best Management Practices (BMPs). A developing trend in the intensification and commercialization of aquaculture encourages the Shrimp Disease Diagnostics Market. Over the years, there has been a growing trend in the intensification and commercialization of aquaculture, which has intensified the epidemics, and this has become one of the major drivers of the Shrimp Disease Diagnostics Market.

Global Shrimp Disease Diagnostics Market: Segmentation Analysis

The Global Shrimp Disease Diagnostics Market is Segmented on the basis of Disease Type, Kits, End User, And Geography.

Shrimp Disease Diagnostics Market, By Disease Type

• Taura Syndrome Virus (TSV)
• Yellow Head/Gill Associated Virus (YHV/GAV)
• Early Mortality Syndrome (EMS)
• White Spot Syndrome Virus (WSSV)
• Others

Based on Disease Type, the market is bifurcated into Taura Syndrome Virus (TSV), Yellow Head/Gill Associated Virus (YHV/GAV), Early Mortality Syndrome (EMS), White Spot Syndrome Virus (WSSV), and Others. The Yellow Head or Gill Associated Virus is forecasted to witness the highest growth throughout the prediction period. On the other hand, the Early Mortality Syndrome commanded the largest size in the Shrimp Disease Diagnostics Market.

Shrimp Disease Diagnostics Market, By Kits

• Assay Based Kits
• Rapid Testing Kits

Based on Kits, the market is bifurcated into Assay Based Kits and Rapid Testing Kits. The Assay Based Kit is accounted to hold the largest size in the Shrimp Disease Diagnostics Market, and it is anticipated to grow at the fastest CAGR during the projection period.

Shrimp Disease Diagnostics Market, By End User

• Fisheries
• Aquaculture and Marine Laboratories
• Education and Research Institutes

Based on End User, the market is bifurcated into Fisheries, Aquaculture and Marine Laboratories, and Education and Research Institutes. The Aquaculture & Marine Laboratories commanded the largest size in the Shrimp Disease Diagnostics Market. On the other hand, Fisheries is estimated to grow at the fastest CAGR during the forecast period.

Shrimp Disease Diagnostics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, the Global Shrimp Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Asia-Pacific commanded the largest size in the Shrimp Disease Diagnostics Market, and it is foreseen to grow at the fastest CAGR during the forecast period.

Key Players

The “Global Shrimp Disease Diagnostics Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Thermo Fisher Scientific, AquaBounty Technologies, Inc., REAGEN LLC, GeneReach Biotechnology Corp., Speedy Assay Sdn Bhd, HiMedia Laboratories.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations, and Agreements

• In October 2020, Thermo Fisher Scientific announced a collaboration agreement with the newly founded Terasaki Innovation Center (TIC) to accelerate the discovery and development of new pathways and tools for diagnosing and managing transplant patients. Thermo Fisher will have the first choice to produce innovative technologies developed by the TIC for use by doctors, laboratories, and transplant centers around the world as a result of this collaboration.

Mergers and Acquisitions

• In April 2021, Thermo Fisher Scientific has agreed to acquire clinical research business PPD for $17.4 billion, the companies said this morning, in a deal that further consolidates contract research organizations (CROs) into a handful of corporate behemoths. The purchase of PPD is a logical extension for Thermo Fisher, allowing it to supply these customers with vital clinical research services and engage with them in new and interesting ways as they advance a scientific hypothesis to an approved treatment rapidly, consistently, and cost-effectively.

Product Launches and Product Expansions

• In October 2020, Shrimp Improvement Systems (SIS), a shrimp breeding corporation based in the United States, has developed the Hardy Line Vannamei shrimp broodstock in India, intending to promote rapid shrimp growth in the face of disease. This line was created to withstand the harsh conditions found on farms. As a result, it is more resistant to disease outbreaks, retains its ability to develop quickly, and has a high fecundity.